✦ LIBER ✦

Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study

✍ Scribed by A. Ardizzoia; M. Acquati; D. Fagnani; M. Giordano; M. Visini; A. Scanni; A. Quattrone; O. Fusco; C. Vergani; C. Casartelli; P. Tagliabue; F. Malugani on behalf of POLONORD Group

Publisher: Springer
Year: 2004
Tongue: English
Weight: 101 KB
Volume: 182
Category: Article
ISSN: 0341-2040
DOI: 10.1007/s00408-003-1039-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with docetaxel and l

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

✍ Jaime Feliu; Jose Luis Firvida; Javier Castro; Catherina Madroñal; Angeles Rodrí 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB

Doublet regimen of cisplatin plus doceta

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB

Weekly combination chemotherapy with doc

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Donna Carrell; Ronald L. Drengler; Carroll Scroggin Jr.; F. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract ## BACKGROUND The goal of the current study was to evaluate the feasibility, toxicity, and efficacy of a novel combination of weekly docetaxel and gemcitabine for elderly patients and patients with poor performance status who had advanced‐stage small cell lung carcinoma (SCLC). ## MET